These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 31621850

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial Schistosoma mansoni Infection Prevalence: A Cluster Randomized Trial.
    Secor WE, Wiegand RE, Montgomery SP, Karanja DMS, Odiere MR.
    Am J Trop Med Hyg; 2020 Feb; 102(2):318-327. PubMed ID: 31802733
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
    Shen Y, King CH, Binder S, Zhang F, Whalen CC, Evan Secor W, Montgomery SP, Mwinzi PNM, Olsen A, Magnussen P, Kinung'hi S, Phillips AE, Nalá R, Ferro J, Aurelio HO, Fleming F, Garba A, Hamidou A, Fenwick A, Campbell CH, Colley DG.
    BMC Infect Dis; 2017 Sep 29; 17(1):652. PubMed ID: 28962552
    [Abstract] [Full Text] [Related]

  • 7. Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research.
    Colley DG, Fleming FM, Matendechero SH, Knopp S, Rollinson D, Utzinger J, Castleman JD, Kittur N, King CH, Campbell CH, Kabole FM, Kinung'hi S, Ramzy RMR, Binder S.
    Am J Trop Med Hyg; 2020 Jul 29; 103(1_Suppl):125-134. PubMed ID: 32400345
    [Abstract] [Full Text] [Related]

  • 8. Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.
    Abudho BO, Ndombi EM, Guya B, Carter JM, Riner DK, Kittur N, Karanja DMS, Secor WE, Colley DG.
    Am J Trop Med Hyg; 2018 May 29; 98(5):1397-1402. PubMed ID: 29532768
    [Abstract] [Full Text] [Related]

  • 9. Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections.
    Karanja DMS, Awino EK, Wiegand RE, Okoth E, Abudho BO, Mwinzi PNM, Montgomery SP, Secor WE.
    PLoS Negl Trop Dis; 2017 Oct 29; 11(10):e0006033. PubMed ID: 29059190
    [Abstract] [Full Text] [Related]

  • 10. Schistosoma mansoni Mass Drug Administration Regimens and Their Effect on Morbidity among Schoolchildren over a 5-Year Period-Kenya, 2010-2015.
    Sircar AD, Mwinzi PNM, Onkanga IO, Wiegand RE, Montgomery SP, Secor WE.
    Am J Trop Med Hyg; 2018 Aug 29; 99(2):362-369. PubMed ID: 29893197
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya.
    Abudho BO, Guyah B, Ondigo BN, Ndombi EM, Ireri E, Carter JM, Riner DK, Kittur N, Karanja DMS, Colley DG.
    Infect Dis Poverty; 2020 Jun 15; 9(1):67. PubMed ID: 32539826
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparing the performance of circulating cathodic antigen and Kato-Katz techniques in evaluating Schistosoma mansoni infection in areas with low prevalence in selected counties of Kenya: a cross-sectional study.
    Okoyo C, Simiyu E, Njenga SM, Mwandawiro C.
    BMC Public Health; 2018 Apr 11; 18(1):478. PubMed ID: 29642875
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High level of Schistosoma mansoni infection in pre-school children in Sierra Leone highlights the need in targeting this age group for praziquantel treatment.
    Hodges MH, Paye J, Koroma MM, Nyorkor ED, Fofonah I, Zhang Y.
    Acta Trop; 2012 Nov 11; 124(2):120-5. PubMed ID: 22820025
    [Abstract] [Full Text] [Related]

  • 18. Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa.
    King CH, Kittur N, Binder S, Campbell CH, N'Goran EK, Meite A, Utzinger J, Olsen A, Magnussen P, Kinung'hi S, Fenwick A, Phillips AE, Gazzinelli-Guimaraes PH, Dhanani N, Ferro J, Karanja DMS, Mwinzi PNM, Montgomery SP, Wiegand RE, Secor WE, Hamidou AA, Garba A, Colley DG.
    Am J Trop Med Hyg; 2020 Jul 11; 103(1_Suppl):14-23. PubMed ID: 32400356
    [Abstract] [Full Text] [Related]

  • 19. Insufficiency of annual praziquantel treatment to control Schistosoma mansoni infections in adult women: A longitudinal cohort study in rural Tanzania.
    Mishra P, Colombe S, Paul N, Mlingi J, Tosiri I, Aristide C, Gao J, Kashangaki P, Nagai H, Kalluvya SE, de Dood CJ, Corstjens PL, Mngara J, van Dam GJ, Downs JA.
    PLoS Negl Trop Dis; 2019 Nov 11; 13(11):e0007844. PubMed ID: 31751333
    [Abstract] [Full Text] [Related]

  • 20. Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel.
    Kemal M, Tadesse G, Esmael A, Abay SM, Kebede T.
    BMC Res Notes; 2019 Apr 05; 12(1):211. PubMed ID: 30953565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.